Folinic Acid Supplementation in Autism Spectrum Disorder: Mitigating Safety Concerns Amid Rising Off-Label Use
Volume 64
Publish Date: March 23, 2026
Dua Fatima Sherwani
Syeda Abeeha Hasan
Dua Ul Khair
Aisha Hanif
Full Text
Published In
Neuropsychiatric Investigation
Volume 64
Pages: 1-2
History
Published Online: March 23, 2026
Dua Fatima Sherwani
Jinnah Sindh Medical University, Karachi, Pakistan
Syeda Abeeha Hasan
Jinnah Sindh Medical University, Karachi, Pakistan
Dua Ul Khair
Jinnah Sindh Medical University, Karachi, Pakistan
Aisha Hanif
Jinnah Sindh Medical University, Karachi, Pakistan
Sherwani, D. F., Hasan, S. A., Khair, D. U., & Hanif, A. (2026). Folinic Acid Supplementation in Autism Spectrum Disorder: Mitigating Safety Concerns Amid Rising Off-Label Use. Neuropsychiatric Investigation, 64, 1–2. https://doi.org/10.5152/NeuropsychiatricInvest.2026.25079
Article Info
Published In
Journal
Neuropsychiatric Investigation
Volume / Issue
Volume 64
Pages
1-2
History
Published Online
March 23, 2026
Affiliations
Dua Fatima Sherwani
Jinnah Sindh Medical University, Karachi, Pakistan
Syeda Abeeha Hasan
Jinnah Sindh Medical University, Karachi, Pakistan
Dua Ul Khair
Jinnah Sindh Medical University, Karachi, Pakistan
Aisha Hanif
Jinnah Sindh Medical University, Karachi, Pakistan
Cite this Article
Sherwani, D. F., Hasan, S. A., Khair, D. U., & Hanif, A. (2026). Folinic Acid Supplementation in Autism Spectrum Disorder: Mitigating Safety Concerns Amid Rising Off-Label Use. Neuropsychiatric Investigation, 64, 1–2. https://doi.org/10.5152/NeuropsychiatricInvest.2026.25079
Share
https://doi.org/10.5152/NeuropsychiatricInvest.2026.25079